In fact, metabolic adaptation and reprogramming are crucial in gliomagenesis, with glutamine starvation enhancing the expression of enzymes such as PSAT1, SHMT2, and MTHFD2, the latter of which emerges as a promising therapeutic target due to its elevated levels in GBM. The gene discussed is PSAT1; the disease is glioblastoma.